Efficacy and safety of interferon treatment in elderly patients with chronic hepatitis C in Japan: A retrospective study using the Japanese Interferon Database-Reference-Cited by-同舟云学术

Efficacy and safety of interferon treatment in elderly patients with chronic hepatitis C in Japan: A retrospective study using the Japanese Interferon Database

Published:2014-10-14 Issue:8 Volume:45 Page:829-836
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Sato Izumi¹,Shimbo Takuro²,Kawasaki Yohei³,Mizokami Masashi⁴,Masaki Naohiko⁴

Affiliation:

1. Department of Clinical Study and Informatics; Center for Clinical Sciences; National Center for Global Health and Medicine; Tokyo Japan

2. Ohta Nishinouchi Hospital; Fukushima Japan

3. Department of Mathematics; Tokyo University of Science; Tokyo Japan

4. The Research Center for Hepatitis and Immunology; National Center for Global Health and Medicine; Chiba Japan

Funder

Ministry of Health, Labour and Welfare

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hepr.12419/fullpdf

Reference17 articles.

1. WHO Hepatitis C Fact sheet N°164 2014 http://who.int/mediacentre/factsheets/fs164/en/index.html

2. Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status;Di Bisceglie;Am J Gastroenterol,2003

3. Global challenges in liver disease;Williams;Hepatology,2006

4. Global epidemiology of hepatitis C virus infection;Shepard;Lancet Infect Dis,2005

5. Peginterferon alfa-2a is superior to peginterferon alfa-2b in the treatment of naive patients with hepatitis C virus infection: meta-analysis of randomized controlled trials;Singal;Dig Dis Sci,2011

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of glecaprevir and pibrentasvir in Japanese patients with hepatitis C virus infection aged 75 years or older;BMC Gastroenterology;2022-04-28

2. Safety and efficacy of directly‐acting antiviral therapy for chronic hepatitis C virus in elderly people;AGING MEDICINE;2021-12

3. Frailty Status Predicts New Long-term Care Insurance Certification in Hepatitis C Patients Receiving Antiviral Therapy;Anticancer Research;2021-07-19

4. Predicting Treatment Failure for Initiators of Hepatitis C Virus Treatment in the era of Direct-Acting Antiviral Therapy;Frontiers in Pharmacology;2020-11-13

5. Chronic Hepatitis C in Elderly Patients: Current Evidence with Direct-Acting Antivirals;Drugs & Aging;2018-02